Enhancing Healing in Infants: Prolacta's Innovative Fortifier
Good News for Parents: Innovative Nutrition Support for Fragile Infants
In the realm of neonatal care, particularly during Gastroschisis Awareness Month, a beacon of hope shines for families facing the challenges of gastroschisis. This condition, a rare gastrointestinal birth defect affecting approximately 1 in every 2,400 newborns annually, often necessitates immediate surgical intervention for optimal outcomes. Prolacta Bioscience has introduced an invaluable solution: the Surgifort human milk fortifier. This innovative product, FDA-approved, ensures that fragile infants can receive the utmost nutrition during their crucial recovery period.
Understanding the Importance of Nutritional Support After Surgery
Newborns recovering from surgically corrected gastroschisis require significant nutritional support to help them heal and grow. The turbulent journey they undergo makes it essential for them to have a strong nutritional foundation. Surgifort, a concentrated human milk-based fortifier, provides the necessary macronutrients tailored specifically for these delicate patients. With a composition free of cow milk and rooted in 100% donor breast milk, Surgifort promises optimal nutrient absorption during this critical stage.
Nutritional Needs Specially Crafted
Babies who have undergone surgery for gastroschisis often face challenges with feeding and nutrient absorption, emphasizing the need for specialized nutritional solutions. "Surgifort fortifier delivers on this front by bringing the clinically validated benefits of human milk to these vulnerable infants," stated Dr. Melinda Elliott, a leading neonatologist at Prolacta. Recognizing the unique requirements in this population, Surgifort aims to bridge the gap in nutritional care, enhancing the quality of life for medically fragile infants.
Progress in Creating an Effective Nutrition Solution
Notably, the Surgifort fortifier has undergone rigorous evaluation, establishing its effectiveness in improving weight gain velocity in infants recovering from gastroschisis surgery. Its formulation is not merely about adding nutrients; it's about meticulously crafting a solution that ensures the appropriate balance of calories and protein needed for these infants' dietary management. Evidence suggests that those on the Surgifort regimen experience a remarkable weight gain from the initiation of the fortifier until its discontinuation.
Prolacta’s Committed Approach to Infant Health
Prolacta Bioscience stands at the forefront of advancing infant health through innovative approaches to nutrition. Over 125,000 extremely premature infants worldwide have benefitted from their human milk-based products, which are rooted in extensive peer-reviewed research. Having pioneered the first and only FDA-approved fortifier specifically for term infants, Prolacta embodies a commitment to quality and sustainability in neonatal care. Their stringent manufacturing processes, including vat pasteurization, ensure the safety of their products while maintaining nutritional integrity.
Continuing the Journey of Innovation in Neonatal Care
As we celebrate advancements during Gastroschisis Awareness Month, it’s vital for healthcare professionals and parents to stay informed about effective nutritional support options. Prolacta’s Surgifort fortifier not only plays a critical role in the healing journey but also highlights the importance of tailored nutrition in improving outcomes for fragile infants. Its unique formulation bridges the nutritional gap, ensuring these young patients have the best possible foundation for growth and recovery.
Frequently Asked Questions
What is Surgifort?
Surgifort is a human milk fortifier developed by Prolacta Bioscience designed specifically for infants recovering from gastroschisis surgery.
How does Surgifort benefit infants recovering from surgery?
This product provides concentrated nutrition, essential for the growth and healing of fragile infants, ensuring they receive the right amount of calories and protein.
Why is donor breast milk used in Surgifort?
Donor breast milk is used because it offers the optimal nutritional profile needed for these infants and reduces the risk of allergic reactions compared to cow milk-based products.
What are the key components of Surgifort?
Surgifort contains protein, fat, carbohydrates from pasteurized donor human milk, and essential added minerals to support infant recovery.
Is Surgifort FDA-approved?
Yes, Surgifort is the first and only FDA-approved human milk-based fortifier specifically made for term infants recovering from gastroschisis surgery.
About The Author
Contact Henry Turner privately here. Or send an email with ATTN: Henry Turner as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.